Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Jeet will be a trusted partner in cardiovascular care
CiplaMed 2.0 leverages advanced analytics and automation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Subscribe To Our Newsletter & Stay Updated